Dr Somaiah discusses the importance of molecular testing and having a multidisciplinary team in the treatment of gastrointestinal stromal tumors.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Gastrointestinal Stromal Tumor(GIST). This video enumerates the salient aspects of GIST including pathogenesis, morphological features, clinical features, and treatment aspects.


Also watch:
https://www.youtube.com/playli....st?list=PL0-Q_iDcO3a

#Gastrointestinal stromal tumor
#GIST
#USMLE
#NEET PG
#PLAB
#FMCG
#High Yields
#Case study


Common mesenchymal tumor of GI Tract
Arises from the interstitial cells of Cajal within the myenteric plexus of the muscularis propria
Extragastrointestinal GIST: GIST arising outside of the gastrointestinal tract Common sites include -omentum, mesentery, retroperitoneum,pleura
Carney triad- a nonhereditary syndrome of GIST, paraganglioma, and pulmonary chondroma that occurs primarily in females.
GIST tumors can also be seen as a part of neurofibromatosis type 1.
Majority of GIST tumors have KIT or PDGFRA mutation. Both trigger the troskine kinase receptor phosporylation leading to cell growth proliferation and survival.
GISTs without mutated KIT or PDGFRA often have mutations in genes encoding components of the mitochondrial succinate dehydrogenase complex (SDHA, SDHB, SDHC, SDHD)cycle.
Mutations causing loss of succinate dehydrogenase function, are often inherited in the germline and confer an increased risk for GIST,pulmonary chondroma and paraganglioma (Carney-Stratakis syndrome).
Gross Findings:
-GISTs averages 5-6 cm with size varying from 0.5-40 cm in diameter.
-They usually form a solitary, well-circumscribed, fleshy mass.
-The overlying mucosa is frequently ulcerated, and the cut tumor surface has a fleshy, tan-pink, whorled appearance with occasional areas of haemorrhage, cystic changes.
-Metastases can form multiple serosal nodules throughout the peritoneal cavity or within the liver, but spread outside of the abdomen is uncommon.
GISTs are classified as:-
Spindle cell type : proliferation of thin spindle cells
Epithelioid type: proliferation of plumper, epithelial-appearing cells
Mixtures of the two patterns are common.
The most useful diagnostic markers are DOG1,KIT (CD117), which is immunohistochemically detectable in Cajal cells and 95% of gastric GISTs.
CD34, PDGFRa may also stain positive.
Negative for SMA(variable), S100
More common in 6th decade,males and females with almost equal incidence
Symptoms of GISTs at presentation are typically related to mass effects.
Mucosal ulceration can cause blood loss, and approximately half of individuals with GISTs present with anemia or related symptoms.
GISTs may also be discovered incidentally during radiologic imaging, endoscopy, or abdominal surgery performed for other reasons.
Complete surgical resection is the primary treatment for localized gastric GIST.
The prognosis correlates with tumor size, mitotic index, and location, with gastric GISTs being less aggressive than those arising in the small intestine.
Recurrence or metastasis is rare for gastric GISTs smaller than 5 cm but common for mitotically active tumors larger than 10 cm.
Tumors with mutations in KIT or PDGFRA often respond to the tyrosine kinase inhibitor imatinib, whereas tumors without these mutations are generally resistant.

-~-~~-~~~-~~-~-
Please watch: "Bronchiectasis-commonest causes. 5 lethal consequences of untreated Bronchiectasis-usmle, neet pg "
https://www.youtube.com/watch?v=-5-Q_bbdZu4
-~-~~-~~~-~~-~-

Neeta Somaiah, MD, discusses treatment options in gastrointestinal stromal tumors, the development of resistance to treatment, and secondary mutations of tumors.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

What is Cancer? Simply put, cancer occurs when cells in the body start to grow out of control.

In this video, experts focus on the symptoms, diagnosis and treatment procedures of two types of cancers. They are soft tissue sarcomas, which begin in the soft tissues of the body, and gastrointestinal stromal tumours (GIST), which begin in the gastrointestinal tract.

Chaptering
==========
0:00 - Introduction
0:37 - 4 Major Types of Sarcomas
0:59 - Soft Tissue Sarcoma
3:25 - Gastrointestinal Stromal Tumour (GIST)
4:09 - Treatment for GIST
5:03 - National Cancer Centre hotlines

About
=====
National Cancer Centre (NCCS), is home to the largest number of surgeons, oncologists and researchers in Southeast Asia. We see close to 65% of Singapore’s public sector cancer patients, attending to over 150,000 patient visits every year. Each patient who walks through our door is treated with kindness and care.

FREE PDF downloads for CONQUERING CANCER (SingHealth Healthy Living Series)
===========================================================
https://www.singhealth.com.sg/....patient-care/patient


Trusted healthcare tips from our care teams
===================================
https://healthxchange.sg


Health Buddy: the all-in-one mobile app
=================================
https://www.singhealth.com.sg/....patient-care/patient
LAUNCH APP NOW: https://for.sg/hbapp

Gross and microscopic description of a GIST.

Video source: Pathweb
Register for FREE access to Pathweb: https://nus.syd1.qualtrics.com..../jfe/form/SV_aeYDYT8

Pathweb online resource: https://medicine.nus.edu.sg/pathweb/
Pathweb instagram: https://www.instagram.com/pathweb/

A gastrointestinal stromal tumor (GIST) is a disease in which abnormal cells form in the tissues of the gastrointestinal tract. Genetic factors can increase the risk of having a gastrointestinal stromal tumor. To know more, contact our experts on 8282824444.
#BMCRaipur #BalcoMedicalCentre #VMRF #GICancer #colorectalcancer #colorectalcancer #livercancer #coloncancer #pancreaticcancer #analcancer #appendixcancer #gallbladdercancer #CancerFreeSociety #cancertreatment #cancerpatient #Chhattisgarh #NayaRaipur

Visit our website: https://bit.ly/2F9wiXu

Get in touch with us:
Facebook: https://bit.ly/3i39uau
Instagram: https://bit.ly/3bsmgNv
Twitter: https://bit.ly/2EU0RB0
Linkedin: https://bit.ly/3lMRJPb
Google: https://bit.ly/2GyBYev


For Appointment Call: 8282823333 or Visit: https://bit.ly/3gYMFU5

Jonathan Strosberg, MD, discusses the case of a woman with a high-grade gastrointestinal stromal tumor and liver metastases treated with imatinib therapy, as well as the role of mutation testing for determining frontline therapy and the use of imaging in diagnosis and response assessment.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/